Literature DB >> 27174354

Iatrogenic Femoral Pseudoaneurysm and Secondary Ipsilateral Deep Vein Thrombosis: An Indication for Early Surgical Exploration.

Marios Papadakis1, Hubert Zirngibl2, Nikolaos Floros2.   

Abstract

Pseudoaneurysm formation often complicates transfemoral interventional procedures. Nonsurgical treatment consists of femoral compression and thrombin injection under ultrasound guidance. We report a 74-year-old man who was diagnosed with a pseudoaneurysm, following coronary angiography. Duplex ultrasound revealed deep vein thrombosis of the ipsilateral common femoral vein. Ultrasound-guided thrombin injection was unsuccessfully performed, and the patient subsequently underwent surgical exploration for repair of the pseudoaneurysm and release of the venous compression. The increased local inflammation, because of the thrombosis, added in surgical difficulties. We conclude that early surgical intervention should be considered as a primary strategy in patients with femoral pseudoaneurysms and deep vein thrombosis secondary to femoral compression.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27174354     DOI: 10.1016/j.avsg.2015.12.019

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  3 in total

1.  Iatrogenic Pseudoaneurysm: An Uncommon Cause of Deep Vein Thrombosis.

Authors:  Muhammad Khalid; Ghulam Murtaza; Majd Kanaa; Vijay Ramu
Journal:  Cureus       Date:  2018-03-27

2.  Iatrogenic Femoral Arteriovenous Fistula with Pseudoaneurysm Associated with Worsening Heart Failure Years after Percutaneous Impella Placement.

Authors:  Andy Y Wang; Ali Al Jabri; Edward R Jewell; Angela L Jellison
Journal:  Case Rep Vasc Med       Date:  2022-06-24

3.  Case presentation of delayed superficial femoral artery pseudoaneurysm causing an acute deep vein thrombosis.

Authors:  Max Murray-Ramcharan; Syed Ali Raza Rizvi
Journal:  J Vasc Surg Cases Innov Tech       Date:  2022-07-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.